Gearing Up for Biosimilars

Publication
Article
BioPharm InternationalBioPharm International-05-15-2017
Volume 2017 eBook
Issue 1
Pages: s22-s26

Contract manufacturers prepare for anticipated biosimilars manufacturing demands through expansion and acquisition.

Compared to traditional small-molecule generics, the R&D costs and development times for biosimilars are significantly greater. With demand for services in the biosimilars space set to soar, many contract development and manufacturing organizations are increasing their capabilities in this field.  Expansions including in-house development, partnerships and joint ventures, or bolt-on acquisitions are summarized.

 

Download BioPharm International's

2017 Outsourcing Resources eBook

.

 

 

 

 

Articles in this issue
Wellspring_225.jpg
Customer Relationship Management in Contract Manufacturing
ColdChain_225.jpg
Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies
TechTransfer_2251495479190893.jpg
Getting Biopharmaceutical Tech Transfer Right the First Time
CMOs_225.jpg
CMOs Tackle New Challenges
Biosimilars_225.jpg
Gearing Up for Biosimilars
InsourcingOutsourcing_225.jpg
Insourcing vs Outsourcing: Choosing the Right Strategy
Operations_225.jpg
Operations and Quality Oversight of CMOs
QualityMetrics_225.jpg
Quality Metrics and CMO Agreement
Audits_225.jpg
Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification
Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
CDMO

5 CDMOs to Watch in 2025

Alicia Bigica
December 20th 2024
Article

Contract development and manufacturing organizations (CDMOs) are more critical than ever as the demand for advanced therapies continues to grow.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Lonza Launches Tailored Service for Smart Capsule Development for Oral Biologics

Feliza Mirasol
December 3rd 2024
Article

Lonza’s new tailored offering leverages the company’s bi-layer capsule manufacturing technology.

Blockchain concept 3d rendering with blue cubes and chains stands.as cryptocurrency digital code chain. | Image Credit: ©kugelwolf - Stock.adobe.com

How Modularization and Digital Delivery are Transforming Pharma Manufacturing

Jordan Ulrich;Dana Tilley
November 26th 2024
Article

Modular and replication strategies are being utilized to meet growing demand for CDMO facilities.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Fujifilm Completes Expansion of Cell Therapy Facility

Nicholas Saraceno
November 22nd 2024
Article

The company officially launched new production suites, a revamp of its development labs, and more at its Thousand Oaks, Calif., cell therapy manufacturing facility.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Launches GMP Cell-Based Potency Testing in US and UK Sites, Boosting Analytical Capabilities

Feliza Mirasol
November 22nd 2024
Article

The company will now include GMP cell-based potency assays at its Cambridge, UK, and San Diego, Calif., sites expanding its early and late phase analytical capabilities.

© 2024 MJH Life Sciences

All rights reserved.